Home/Filings/4/0001390478-14-000047
4//SEC Filing

Galena Biopharma, Inc. 4

Accession 0001390478-14-000047

$SLSCIK 0001390478operating

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 4:36 PM ET

Size

5.9 KB

Accession

0001390478-14-000047

Insider Transaction Report

Form 4
Period: 2014-09-16
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2014-09-16+200,000200,000 total
    Exercise: $2.23Exp: 2024-09-16Common Stock (200,000 underlying)
Footnotes (2)
  • [F1]Granted pursuant to the Issuer's Amended and Restated 2007 Incentive Plan.
  • [F2]The option will vest in 12 equal quarterly installments over three years beginning on August 21, 2014 (the retroactive effective date of the Reporting Person's employment agreement), provided, in each case, that the Reporting Person remains in continuous employ of the Issuer through such quarterly vesting date.

Issuer

Galena Biopharma, Inc.

CIK 0001390478

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001390478

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:36 PM ET
Size
5.9 KB